Skip to content

Safety and Efficacy of Ultrasound Guided Vascular Access

Safety and Efficacy of Ultrasound Guided Vascular Access

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05118581
Enrollment
100
Registered
2021-11-12
Start date
2021-12-01
Completion date
2022-12-30
Last updated
2021-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Access, Ultrasound Guided Vascular Access

Brief summary

Vascular access involves central and peripheral vein accesses and arterial accesses. Central venous catheterization is widely used in clinical practice for diverse purposes, including hemodialysis for end stage renal failure, invasive hemodynamic monitoring, radiological studies, infusion of drugs that cannot be administered via peripheral vessels, administration of parenteral nutrition, vascular access in patients whose peripheral veins are difficult to be catheterized and for miscellaneous purposes that require access to large caliber vessels. Arterial cannulation is used for invasive arterial pressure monitoring and to ensure access for diagnostic and therapeutic interventions. In the United States and United Kingdom, guidelines have recommended the use of ultrasound guidance to reduce complications and improve success in central venous catheterization.

Interventions

Arterial or venous catheterization guided by ultrasound

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* · Adult patients who need vascular access (arterial or venous)

Exclusion criteria

* · Patients with local infection in the area targeted for vascular access. * Patients with severe generalized infection and other skin diseases or lesions. * patients with history of DVT of the target vein and or pulmonary embolism. * Patients with untreated coagulopathy (INR \>1.5 or platelets \<50000mm3)

Design outcomes

Primary

MeasureTime frameDescription
Incidence of adverse effects of ultrasound guided vascular accessone yearNumber of participants with adverse effects after ultrasound guided vascular access

Contacts

Primary ContactMostafa M Ahmed, resident
mostafaelsayed@med.sohag.edu.eg01004115144

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026